Constellation Investments’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$423K Buy
4,089
+206
+5% +$19.9K 0.08% 270
2015
Q4
$387K Buy
3,883
+103
+3% +$10.1K 0.07% 283
2015
Q3
$345K Hold
3,780
0.07% 291
2015
Q2
$401K Buy
3,780
+103
+3% +$11.4K 0.08% 281
2015
Q1
$420K Buy
3,677
+103
+3% +$11.8K 0.08% 278
2014
Q4
$394K Buy
3,574
+206
+6% +$21.7K 0.08% 281
2014
Q3
$329K Buy
3,368
+103
+3% +$10.1K 0.07% 293
2014
Q2
$329K Hold
3,265
0.08% 292
2014
Q1
$300K Hold
3,265
0.07% 303
2013
Q4
$295K Buy
3,265
+309
+10% +$26.7K 0.08% 292
2013
Q3
$236K Buy
2,956
+206
+7% +$16.2K 0.07% 310
2013
Q2
$200K Buy
+2,750
New +$206K 0.07% 322

Other funds holding ZBH

Constellation Investments's ZBH Position: Q1 2016 in Review

Constellation Investments increased its Zimmer Biomet (ZBH) stake by 5.3% in Q1 2016, buying an estimated $19.9K and bringing the position to 4,089 shares worth $423K. The position accounts for 0.08% of the portfolio, ranked #270.

Constellation Investments first reported a position in ZBH in Q2 2013 and has held it in 12 quarters since. 746 funds tracked by Wall St. Rank hold ZBH as of Q1 2016.

  • Constellation Investments held 4,089 shares of Zimmer Biomet worth $423K as of Q1 2016.
  • Constellation Investments bought 206 Zimmer Biomet shares in Q1 2016, an estimated $19.9K.
  • Zimmer Biomet made up 0.08% of Constellation Investments's portfolio in Q1 2016, its #270 holding.
  • Constellation Investments first reported a position in Zimmer Biomet in Q2 2013 and has held it in 12 quarters since.
  • 746 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2016.

Based on Constellation Investments's 13F filing for Q1 2016, filed 28 Apr 2016.